TileDB Inc. has released a new Max server size for notebook instances on TileDB Cloud.

Over the past decade, Greece has seen a significant increase in startup activity in diverse sectors, including fintech, tourism tech, agritech, healthtech, and creative industries, all supported by incubators, accelerators, and co-working spaces. This diversity reflects the country's ability to leverage its strengths across various domains. The country's supportive regulatory environment, coupled with a growing pool of skilled tech talent and robust infrastructure, has fostered the growth of numerous successful tech companies. International recognition and funding opportunities are also on the rise, attracting both local entrepreneurs and global investors to Greece's promising tech landscape

Precision medicine is revolutionizing healthcare – by optimizing the efficiency and therapeutic benefit for particular groups of patients, especially by using genetic or molecular profiling. This approach enables a range of health disciplines, including disease prediction, prevention and the resulting treatments, diagnostic screening for prenatal and newborns, and screening for rare diseases and cancer types. For life sciences, the ability to peer into high-resolution molecular profiles has opened up the way we hunt for new drugs and targets.As exciting as these possibilities are, precision medicine relies on being able to handle and analyze vast amounts of complex data with a great degree of nimbleness and agility. With faster, more affordable technologies, organizations are generating hundreds of terabytes of genomic data per month, and it’s estimated that genomics alone will generate up to 40 exabytes of data per year by 2025. The explosion of variant data from public and private biobanks, and the advent of multi-omics, in particular, is rendering existing solutions to store and analyze data impractical.A prime example is Phenomic AI, a pioneering biotech company targeting the tumor stroma, a complex barrier that surrounds cancer cells and stops medicines from working. At the core of Phenomic AI’s work is a target discovery platform where scientists can apply machine learning to single cell data amassed at scale, enabling the discovery of novel stromal targets